Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Kevin Buchi currently holds 52,097 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Kevin Buchi has been a net seller of AMRX stock. They have purchased $2.3M and sold $9.1M worth of shares.
J. Kevin Buchi's most recent insider trade was on Jun 29, 2026, when they sold 51,813 shares at $0.00 per share.
J. Kevin Buchi serves as Executive at Amneal Pharmaceuticals, Inc. (AMRX). They have executed 86 insider transactions totaling $11.3M over their tenure at the company.
J. Kevin Buchi holds the position of Executive at Amneal Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
J. Kevin Buchi has shown a selling trading pattern, with $2.3M in total purchases and $9.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by J. Kevin Buchi was on Mar 5, 2010, when they sold $2.1M worth of CEPH shares. This transaction involved 30,000 shares at $70.64 per share.
J. Kevin Buchi currently owns 52,097 shares of Amneal Pharmaceuticals, Inc. (AMRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Kevin Buchi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Kevin Buchi has 86 Form 4 filings on record as an insider at Amneal Pharmaceuticals, Inc..
Set alerts for J. Kevin Buchi and 40,000+ other insiders.